NEWS ·
Did Claude Solve the Riemann Hypothesis? What the Proof Claim Says
Anthropic mathematician Levent Alpöge says he found a proof with Claude. Here’s what he released and what independent experts still need to check.
Read article →COMPOUND STOCKS / COMPANY PROFILE
MARKET DATA / TRADINGVIEW
Explore the historical share price. The chart below is supplied by TradingView, not the SEC, and is separate from the financial results on this page.
Market data may be delayed or unavailable for some securities. Anthropic (NASDAQ:ANT) chart by TradingView. TradingView branding and market-data attribution remain visible.
Claude AI models, enterprise software and developer APIs. Nasdaq-listed since 19 November 2026.
Primary listing reference: Nasdaq ↗. For ADRs, prices refer to the named depositary receipt rather than the local ordinary share.
Nasdaq confirmed on 19 November that Anthropic began public trading under ANT and opened at $111.50 per share. Reuters reported the first session close was $97.17. The $83 issuer offering price on 18 November is a separate allocation price.
Compound checks this company's official filings. International reporting formats require additional verification; no quarterly figures are invented and no separate quarterly articles are automatically published.
ORIGINAL COVERAGE
NEWS ·
Anthropic mathematician Levent Alpöge says he found a proof with Claude. Here’s what he released and what independent experts still need to check.
Read article →NEWS ·
ANT opened 34.3% above its $83 IPO price. See all 23 Anthropic lock-up tranches, the next release date and the biggest 2027 unlocks.
Read article →NEWS ·
Anthropic closed its $93.54bn IPO and separate $26bn placement on 20 November, after an $83 offer, $111.50 debut and $97.17 first close; proceeds to the issuer differ from total deal value.
Read article →COMPANY RESEARCH ·
Anthropic's 17 November linked billing beta allows eligible customers to pay model bills directly. The option changes SaaS margins, procurement and operational liability, with important eligibility and data-governance limits.
Read analysis →COMPANY RESEARCH ·
Anthropic's 12 November private beta lets enterprises run the Managed Agents control plane in their own environment. Local credentials and session history change security responsibility, not the need for model processing or operational discipline.
Read analysis →COMPANY RESEARCH ·
Anthropic's IPO prospectus reveals a $70–$78 price range, a $61bn public share sale at the midpoint, $33.2bn in nine-month sales, almost $901bn in compute commitments, and a difficult valuation equation.
Read analysis →COMPANY RESEARCH ·
Anthropic's 13 November agent architecture guidance makes a subtle commercial point: subscriptions alone won't make unattended AI reliable without durable queues, permissions and recovery.
Read analysis →COMPANY RESEARCH ·
Anthropic's 12 November Claude Meetings beta shifts AI from note-taking toward acting during a call. Its value depends on completed work, permissions and the cost after temporary free usage ends.
Read analysis →COMPANY RESEARCH ·
Anthropic's incident records for 13–14 November distinguish authentication, API, connector and billing failures. The economic test for enterprise AI is completed work, not merely available models.
Read analysis →COMPANY RESEARCH ·
Anthropic says Anvil found stronger safeguard vulnerabilities in 24–48 hours than human bounty testers found over weeks. The commercial value depends on repeatability, external validation and secure deployment.
Read analysis →COMPANY RESEARCH ·
Anthropic's new Fable 5.2 and Mythos 5.2 make difficult AI work faster at a premium token price. The commercial test is cost per successful task, not benchmark rank alone.
Read analysis →COMPANY RESEARCH ·
A huge accounting loss does not establish a cash crisis. Anthropic’s prospective investors still need to interrogate its valuation, cash generation and spending commitments.
Read analysis →SOURCES & LIMITATIONS
Prices and charting are supplied by TradingView and may be delayed. Listing markets and accounting standards vary; foreign 20-F/6-K and local-market financial statements are monitored for review but are not automatically treated as US 10-Q/10-K quarterly earnings. Future research must cite appropriate primary filings and use explicit company tags.
For information only, not personal financial advice. Editorial policy.